Clinical Trial

Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 22, 2024 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study was to evaluate the safety and efficacy of a modified allogeneic hematopoietic stem cell transplantation regimen for aplastic anemia.
Trial Details
NCT Number NCT06378060
Lead Sponsor Hematology department of the 920th hospital
Conditions Severe Aplastic Anemia
Enrollment 30 participants
Start Date 2024-03-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-22